Nicholas P Restifo

Company: Marble Therapeutics

Job title: Chief Scientist, Head of R&D

Seminars:

Panel Discussion: Evaluating Current Treatment Procedures to Identify Gaps & Opportunities in Treatment Protocols 2:00 pm

Evaluating the need for lymphodepletion and other pre-treatment protocols How do we determine timing and order of treatment procedures when prioritizing the patient? How do treatment protocols differ between different patients?Read more

day: Conference Day Two - Track B - PM

Key Qualities of TILs & Hallmarks of Successfully Developing TIL Therapies 9:15 am

Highlighting advantages of TIL poly-clonality and state-of-the-art approaches such as AI/ML to obtain and preserve truly tumor reactive T-cells Identifying gene-modifications to enhance TIL expansion, persistence, and efficacy Discussing current innovations in cell culture methods for effective TIL expansionRead more

day: Conference Day Two